What is the recommended dosage of steroids, such as prednisolone (corticosteroid), for patients with a positive Maddrey's score indicating severe alcoholic hepatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Steroid Dosage for Patients with Positive Maddrey's Score in Alcoholic Hepatitis

For patients with severe alcoholic hepatitis defined by a Maddrey's Discriminant Function (mDF) score ≥32, prednisolone 40 mg daily for 28 days is the recommended standard treatment regimen. 1, 2

Diagnostic Criteria for Severe Alcoholic Hepatitis

  • Severe alcoholic hepatitis requiring steroid therapy is defined by:

    • Maddrey's Discriminant Function (mDF) score ≥32 2, 1
    • MELD score >21 1
    • Glasgow Alcoholic Hepatitis Score (GAHS) ≥9 1
    • Presence of hepatic encephalopathy 1
  • Patients with mild alcoholic hepatitis (mDF <32) generally improve with abstinence and supportive care alone without steroid therapy 1

Standard Steroid Treatment Protocol

  • Prednisolone 40 mg orally once daily for 28 days is the standard recommended regimen 2, 1
  • After completing the 28-day course, prednisolone can be either:
    • Discontinued abruptly, or
    • Tapered over 2 weeks 1
  • The type of corticosteroid used (prednisolone, prednisone, or methylprednisolone) does not significantly affect survival outcomes 3

Monitoring Response to Steroid Treatment

  • Response to steroid therapy should be assessed at day 7 using:

    • The Lille model score 2, 1
    • Early Change in Bilirubin Level (ECBL) 2
  • Based on the Lille model score at day 7, patients are categorized as:

    • Complete responders (score ≤0.16): 91.1% 28-day survival rate 2, 1
    • Partial responders (score 0.16-0.56): 79.4% 28-day survival rate 2, 1
    • Null responders (score ≥0.56): 53.3% 28-day survival rate 2, 1
  • If the Lille score is ≥0.56 (null responder), steroids should be discontinued and alternative therapies considered 2

Therapeutic Window for Steroid Treatment

  • Steroids are most effective in patients with MELD scores between 25-39, providing a 21-30% survival benefit 3
  • Steroid benefit is observed in patients with MELD scores between 21-51 3
  • No survival benefit is seen in patients with MELD scores >51 3

Contraindications to Steroid Therapy

  • Active infection or sepsis 1
  • Gastrointestinal bleeding 1
  • Acute renal failure 1
  • Acute pancreatitis 1

Alternative Treatment for Contraindicated Cases

  • For patients with contraindications to steroids, pentoxifylline 400 mg three times daily for 28 days is recommended as an alternative 2, 1
  • Pentoxifylline is particularly useful in patients with early renal failure or at high risk of hepatorenal syndrome 2
  • However, pentoxifylline is less effective than prednisolone for improving survival 1, 4

Treatment Algorithm

  1. Assess severity using mDF score, MELD, or GAHS
  2. If mDF ≥32 and no contraindications: Start prednisolone 40 mg daily 2
  3. Assess response at day 7 using Lille model 2, 1
  4. If Lille score <0.56: Continue prednisolone for full 28-day course 2, 1
  5. If Lille score ≥0.56: Discontinue steroids and consider alternative approaches 2
  6. If contraindications to steroids exist: Use pentoxifylline 400 mg three times daily 2, 1

Important Caveats

  • Combination therapy with prednisolone plus pentoxifylline does not improve survival compared to prednisolone alone 5, 6, 4, 7
  • Long-term outcomes depend primarily on achieving alcohol abstinence 1
  • Nutritional support is essential alongside pharmacological treatment 2
  • Infection risk is higher in patients receiving prednisolone (13%) compared to those not receiving prednisolone (7%) 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.